3 developmental toxicology I Flashcards
what is developmental toxicology and teratogenesis?
-developmental tox= adverse effects of xenobiotics that occur between conception to puberty (recall diethylstilbestrol)
-teratogenesis= adverse effects of xenos that occur between conception and birth (recall thalidomide)
what are the causes of developmental toxicity?
-known genetic factors (25%)
-known environmental factors (10-15%)
-unknown multifactorial causes (causes)
what are the known genetic factors?
25%
-most common are chromosomal abnormalities and single-gene defects
what are the known environmental factors?
10-15%
-infections (bacteria, viruses) 3%
-maternal factors (ex: disease nutrition) $4
-environmental toxicants and drugs, referred to as teratogens 5%
-ionizing radiation other physical factors (1-2%)
what are the unknown multifactorial causes?
60%
-genetic: environmental interactions
-epigenetics: especially important during gametogenesis (formation of egg and sperm) in parents, and subsequently in early development between zygote and blastocyst stage (referred to as “imprinting”) (environmental exposure to parent changes gene)
what are are the 6 general principles of teratology (birth defects) of Wilson?
- susceptibility to teratogenesis depends on the genotype of the conceptus (baby) and the manner in which this interacts with adverse environmental factors
- susceptibility to teratogenesis varies with the developmental stage (windows) at the time of exposure to an adverse influence
- teratogenic agents act in specific ways (mechanisms) on developing cells and tissues to initiate sequences of abnormal developmental events (pathogenesis)
- the access of adverse influences to developing tissues depends on the nature of the influence (agent) (ADME)
- the four manifestations of deviant development are death, malformation, growth retardation (reduced birth weight) and functional deficit
- manifestations of deviant development increase in frequency and degree as dosage increases, from no effect to the totally lethal level (dose defines the poison, threshold response)
what are principles I & II?
susceptibility
-genotype of embryo-fetus (intrinsic factors) and environment (extrinsic factors, which include maternal factors and external environmental factors) are the major consideration
what are the general developmental stages?
- early development (fertilization to implantation)
- organogenesis (day 21-56 in humans; first trimester)
- fetal period
what is the early development stage?
fertilization to implantation
-usually lower sensitivity to teratogen exposure at this stage
-gastrulation: formation of ectoderm. mesoderm, and endoderm (cell differentiation), and then migration of these cellular “germ layers”
-teratogens can cause malformations of eye, brain and face during this period
what is the organogenesis stage?
day 21-56 in humans; 1st trimester
-highly sensitive developmental stage due to significant cell division, differentiation, migration and “remodeling” during organ and tissue development
-within organogenesis, there are key developmental events that coincide with peaks of sensitivity
-recall thalidomide: amelia (missing limbs) and phocomelia (shortened limbs) due to exposure during this specific period of development (20-36 days after fertilization in humans)
what is the fetal period stage?
2nd and third trimester
-pre-differentiation and organogenesis are referred to as the embryonic period; structural/morphological effects of teratogens are most prevalent
-fetal period involves histogenesis and functional maturation of organs and tissues; thus teratogenic effects are more functional in nature (eg: CNS, behavior, immune system, reproductive system)
-significant growth occurs during fetal period and reduced growth (birth weight) is a common effect of teratogens
what is the big graph of how dose defines the poison in birth?
dose and timing define the poison
what are species differences in organogenesis and functional maturation?
-example: thalidomide causes phovomelia/amelia in humans but not in rats or mice; many other examples
-consider implication for risk assessment when testing chemicals for teratogenicity
what are species differences in organogenesis and functional maturation when going back to ADME?
-back to ADME: consider species differences in appearance of smooth endoplasmic reticulum (SER) in liver (CYP expression)
-in humans SER appears early in gestation (1st trimester, day 40-60) whereas in mice and rats SER appears just before birth
-thus human fetus can detoxify xenobiotics early in development compared to rodents
-however if xenobiotic is bioactivated by CY{ it can be more teratogenic in humans during sensitive organogenesis period
what is of principle 3?
adverse outcome pathway